论文部分内容阅读
已证明在许多用 hMG 和 hCG(hMG/hCG)诱导排卵的病人中黄体期血催乳素(PRL)升高。高 PRL 血症对妇女生殖周期和生育力有不利的影响,包括改变促性腺激素的分泌、卵泡形成及黄体功能障碍。所以 PRL 升高已暗示作为解释 hMG/hCG 治疗周期中排卵和妊娠率之间差异的因素。本文作者研究了使用 hMG/hCG 诱导排卵的病人中黄体期 PRL 升高的发生率和严重性。作者连续分析96例妇女中240个 hMG/hCG 诱导排卵周期。月经第三天开始用 hMG(含 FSH、
Luteal phase prolactin (PRL) has been shown to be elevated in many ovulation-inducing patients with hMG and hCG (hMG / hCG). High PRL hyperlipidemia has adverse effects on women’s reproductive cycle and fertility, including changes in gonadotropin secretion, follicular formation, and corpus luteum dysfunction. So PRL elevation has been implicated as a factor explaining the difference between ovulation and pregnancy rates in hMG / hCG treatment cycles. The authors studied the incidence and severity of elevated PRL in the luteal phase in patients who used ovulation induction hMG / hCG. The authors continually analyzed 240 hMG / hCG induced ovulation cycles in 96 women. The third day of menstruation with hMG (including FSH,